Halozyme Therapeutics Inc. Common Stock vs Sasol Ltd. American Depositary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.94 (market cap $12.58B), while Sasol Ltd. American Depositary Shares trades at $15.05 (market cap $9.25B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is more actively traded (2,179,278 versus 1,222,173). Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Sasol Ltd. American Depositary Shares for 0 Days on average.
| HALO | SSL | |
|---|---|---|
Market Cap | $12.58B | $9.25B |
Volume | 2,179,278 | 1,222,173 |
Sector | Health | Basic Materials |
52-Week High | $115.22 | $15.14 |
52-Week Low | $61.63 | $5.33 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $12.97B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Sasol Limited is a Johannesburg-headquartered chemicals and energy company that uses its proprietary Fischer-Tropsch technology to convert coal, natural gas, and crude-oil feedstocks into fuels and chemical products such as polymers, solvents, surfactants, and ammonia, with operations across Southern Africa and international chemical manufacturing sites, including in US.
Read more on SSL →